Procedural Sedation and Analgesia for Treatment of Adults With Fractures and Dislocations in the Emergency Department

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRegion Zealand

About this trial

The goal of this observational study is to evaluate the effectiveness and safety of different procedural sedation and analgesia methods used for adults with painful fractures requiring reduction treatment in the emergency department.

The main questions it aims to answer are:

* Which sedation and analgesia methods provide the best patient satisfaction and pain relief? * How do different treatment methods affect clinician satisfaction and the occurrence of adverse events?

The investigators will compare different types of procedural sedative and analgesic treatments (such as systemic sedation/analgesia and regional techniques like nerve or hematoma blocks) to see which approach offers the best patient satisfaction and most effective pain control.

Participants will:

Be adult patients with upper or lower extremity fractures or joint dislocations requiring painful reduction procedures.

Receive one of the routinely used sedation or analgesia treatments (or no analgesia) during their emergency department care.

Report their pain levels and satisfaction before, during, and after treatment. Be monitored for any side effects, complications, or use of antidotes. Data will be collected over a six-month period at Odense University Hospital, Holbæk Hospital, and Zealand University Hospital, Køge, following the STROBE guidelines for observational studies.

Eligibility criteria

Qualifiers

Age ≥18.

Reduction treatment of shoulder dislocation

Reduction treatment of elbow dislocation

Reduction treatment of distal radius fractures, application of cast

Disqualifiers

Unable to give informed consent (e.g. unconscious, psychotic or dementia)

Unwilling to participate in the study

Prior inclusion in the study

Already included in another clinical study at the same day/hospital visit

Trial design

Treatments tested in this trial

  • Usual Care

Treatment groups

200 Participants
are divided into 1 treatment group

Sponsors and collaborators

Region Zealand

Lead sponsor

Zealand University Hospital

Collaborator

Odense University Hospital

Collaborator

Holbaek Sygehus

Collaborator